GlassScriptPhysician profile
Adam Sise
NPI 1891010997
$1,072.69
in general payments reported to CMS, 2019-2025
12 companies · $50.80 in 2025
The $50.80 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2020: $68.40 · 2021: $21.56 · 2022: $338 · 2023: $171 · 2024: $260 · 2025: $50.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $482.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $264.65 | 2022-2024 | Clareon |
| Johnson & Johnson Surgical Vision, INC. | $192.65 | 2022-2025 | Tecnis Iol |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $166.74 | 2019-2020 | |
| Beaver-Visitec International, INC. | $128.95 | 2022 | |
| Mallinckrodt Hospital Products INC. | $97.41 | 2023 | Acthar |
| Glaukos Corporation | $48.55 | 2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Novartis Pharmaceuticals Corporation | $44.06 | 2019-2023 | |
| Allergan, INC. | $43.45 | 2021-2022 | |
| Astellas Pharma US INC | $34.88 | 2024 | Izervay |
| Sun Pharmaceutical Industries INC. | $20.42 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Kala Pharmaceuticals, INC. | $11.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Sise listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.